サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1635891

ハンチントン病治療市場レポート：タイプ別、薬剤タイプ別、年齢別、流通チャネル別、エンドユーザー別、地域別、2025-2033年

Huntington's Disease Treatment Market Report by Type, Drug Type, Age, Distribution Channel, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 133 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
ハンチントン病治療市場レポート：タイプ別、薬剤タイプ別、年齢別、流通チャネル別、エンドユーザー別、地域別、2025-2033年
出版日: 2025年01月10日
発行: IMARC
ページ情報: 英文 133 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ハンチントン病治療市場の世界市場規模は2024年に5億7,890万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに24億4,300万米ドルに達し、2025年から2033年の間に17.4％の成長率（CAGR）を示すと予測しています。ハンチントン病の主な動向の増加、先進的な治療薬に対する需要の増加、革新的な治療アプローチの最近の開発は、市場を牽引する重要な要因の一つです。

ハンチントン病は、脳の神経細胞の破壊を進行させる致死的な神経変性疾患です。ハンチントン病の症状には、不随意運動、筋力障害、整理・集中困難、意識障害、不眠、社会的引きこもりなど、さまざまな運動障害、精神障害、認知障害が含まれます。ハンチントン病治療には、抗精神病薬、抗うつ薬、抗パーキンソン病薬、気分安定薬などさまざまな薬剤が使われます。治療過程には、言語療法、作業療法、理学療法、心理療法などのさまざまな治療も含まれます。ハンチントン病治療は、運動障害や精神障害の症状を最小限に抑え、患者が短期間で新しい能力に適応できるように支援し、対処戦略を開発するのに役立ちます。また、日常的な作業や発話の改善、姿勢やバランスの維持、生活の質の向上にも役立ちます。

ハンチントン病治療市場傾向：

世界中でハンチントン病の罹患率が上昇していることが、市場成長を促進する主な要因の1つです。ハンチントン病治療は、不随意運動や身動きの抑制、舞踏病の治療、暴力的な暴発や興奮の抑制、筋力、柔軟性、バランス、協調性の強化などに広く使用されており、その結果、QOLが向上し、食事、コミュニケーション、歩行などの日常的なルーチン作業を遂行する患者の能力が強化されます。さらに、ハンチントン病に伴う運動症状、認知症状、精神症状をコントロールする先進的な薬剤に対する需要の高まりが、市場成長の原動力となっています。これに伴い、ハンチントン病とその根本的な原因に対する理解が深まり、新たな疾患修飾薬の開発が急速に進んでいることも、成長を促す要因となっています。さらに、変異型ハンチンチン（mTT）産生レベルを低下させることでハンチントン病の成長を抑止する革新的な治療アプローチの最近の動向は、市場にプラスの影響を与えています。これとは別に、ハンチンチン（HTT）メッセンジャーリボ核酸（mRNA）と中枢神経系（CNS）全体のそのタンパク質を標的とするアンチセンスオリゴヌクレオチド（ASO）を使用するアンチセンス技術のイントロダクションは、市場の成長を推進しています。さらに、複数の政府による新薬開発促進への取り組みが活発化していることも、市場開拓を後押ししています。その他、ハンチントン病に関する大衆の意識の高まり、ヘルスケア産業の著しい成長、研究開発（R&D）活動への投資の増加、老年人口の増加、適応外治療薬に対する需要の高まりなどが、市場成長を促進すると予測されます。

本レポートで扱う主な質問

  • 2024年の世界のハンチントン病治療市場の市場規模は？
  • 2025-2033年の世界のハンチントン病治療市場の予想成長率は？
  • 世界のハンチントン病治療市場を牽引する主要因は何か？
  • 世界のハンチントン病治療市場に対するCOVID-19の影響は？
  • 世界のハンチントン病治療市場のタイプ別内訳は？
  • 世界のハンチントン病治療市場の薬剤タイプ別の内訳は？
  • 世界のハンチントン病治療市場の年齢による内訳は？
  • 世界のハンチントン病治療市場の流通チャネル別の内訳は？
  • 世界のハンチントン病治療市場における主要地域は？
  • 世界のハンチントン病治療市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のハンチントン病治療市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 対症療法
    • 市場動向
    • 市場予測
  • 疾患修飾療法
    • 市場動向
    • 市場予測

第7章 市場内訳：薬剤タイプ別

  • 承認医薬品
    • 市場動向
    • 主要セグメント
      • テトラベナジン
      • デュテトラベナジン
    • 市場予測
  • 適応外医薬品
    • 市場動向
    • 市場予測

第8章 市場内訳：年齢別

  • 50歳未満
    • 市場動向
    • 市場予測
  • 50歳以上
    • 市場動向
    • 市場予測

第9章 市場内訳：流通チャネル別

  • ドラッグストアおよび小売薬局
    • 市場動向
    • 市場予測
  • 病院薬局
    • 市場動向
    • 市場予測
  • オンライン薬局
    • 市場動向
    • 市場予測

第10章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 在宅ケア
    • 市場動向
    • 市場予測
  • 専門クリニック
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第11章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第12章 促進要因・抑制要因・機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AOP Health
    • Apotex Inc.
    • Dr. Reddy's Laboratories Ltd.
    • H. Lundbeck A/S
    • Hikma Pharmaceuticals PLC
    • Lupin Limited
    • Prilenia Therapeutics
    • Sun Pharmaceutical Industries Limited
    • Teva Pharmaceutical Industries Ltd.
    • Vaccinex Inc.
図表

List of Figures

  • Figure 1: Global: Huntington's Disease Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Huntington's Disease Treatment Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Huntington's Disease Treatment Market: Breakup by Drug Type (in %), 2024
  • Figure 6: Global: Huntington's Disease Treatment Market: Breakup by Age (in %), 2024
  • Figure 7: Global: Huntington's Disease Treatment Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Huntington's Disease Treatment Market: Breakup by End User (in %), 2024
  • Figure 9: Global: Huntington's Disease Treatment Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Huntington's Disease Treatment (Symptomatic Treatment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Huntington's Disease Treatment (Symptomatic Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Huntington's Disease Treatment (Disease-modifying Therapies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Huntington's Disease Treatment (Disease-modifying Therapies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Huntington's Disease Treatment (Approved Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Huntington's Disease Treatment (Approved Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Huntington's Disease Treatment (Off-label Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Huntington's Disease Treatment (Off-label Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Huntington's Disease Treatment (Below 50 Years) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Huntington's Disease Treatment (Below 50 Years) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Huntington's Disease Treatment (Above 50 Years) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Huntington's Disease Treatment (Above 50 Years) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Huntington's Disease Treatment (Drug Store and Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Huntington's Disease Treatment (Drug Store and Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Huntington's Disease Treatment (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Huntington's Disease Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Huntington's Disease Treatment (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Huntington's Disease Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Huntington's Disease Treatment (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Huntington's Disease Treatment (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Huntington's Disease Treatment (Homecare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Huntington's Disease Treatment (Homecare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Huntington's Disease Treatment (Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Huntington's Disease Treatment (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Huntington's Disease Treatment (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Huntington's Disease Treatment (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: North America: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: North America: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: United States: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: United States: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Canada: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Canada: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Asia-Pacific: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Asia-Pacific: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: China: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: China: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Japan: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Japan: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: India: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: India: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: South Korea: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: South Korea: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Australia: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Australia: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Indonesia: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Indonesia: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Others: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Others: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Europe: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Europe: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Germany: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Germany: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: France: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: France: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: United Kingdom: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: United Kingdom: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Italy: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Italy: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Spain: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Spain: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Russia: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Russia: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Latin America: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Latin America: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Brazil: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Brazil: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Mexico: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Mexico: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Others: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Others: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Middle East and Africa: Huntington's Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Middle East and Africa: Huntington's Disease Treatment Market: Breakup by Country (in %), 2024
  • Figure 84: Middle East and Africa: Huntington's Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Global: Huntington's Disease Treatment Industry: Drivers, Restraints, and Opportunities
  • Figure 86: Global: Huntington's Disease Treatment Industry: Value Chain Analysis
  • Figure 87: Global: Huntington's Disease Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Huntington's Disease Treatment Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Huntington's Disease Treatment Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Huntington's Disease Treatment Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
  • Table 4: Global: Huntington's Disease Treatment Market Forecast: Breakup by Age (in Million USD), 2025-2033
  • Table 5: Global: Huntington's Disease Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Huntington's Disease Treatment Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 7: Global: Huntington's Disease Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Huntington's Disease Treatment Market: Competitive Structure
  • Table 9: Global: Huntington's Disease Treatment Market: Key Players
目次
Product Code: SR112025A6883

The global Huntington's disease treatment market size reached USD 578.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,443 Million by 2033, exhibiting a growth rate (CAGR) of 17.4% during 2025-2033. The rising incidences of Huntington's disease, the increasing demand for advanced drugs for the disease treatment, and recent development of innovative therapeutic approaches represent some of the key factors driving the market.

Huntington's disease refers to a fatal neurodegenerative disorder that causes the progressive breakdown of nerve cells in the brain. Its symptoms include various movement, psychiatric, and cognitive impairments, such as involuntary jerking, muscle problems, difficulty in organizing and focusing, lack of awareness, insomnia, and social withdrawal. Huntington's disease treatment involves the application of various drugs, such as antipsychotics, antidepressants, antiparkinsonians, and mood-stabilizing drugs. The treatment process also includes various therapies, such as speech, occupational, physical, and psychotherapy. Huntington's disease treatment helps in minimizing the symptoms of movement and psychiatric disorders, assists patients in adapting to new abilities in a shorter time, and develops coping strategies. It also aids in improving everyday tasks, speech, maintaining posture and balance, and enhancing the quality of life.

Huntington's Disease Treatment Market Trends:

The rising incidence of Huntington's disease across the globe is one of the primary factors driving the market growth. Huntington's disease treatment is widely used to suppress involuntary jerking and writhing movement, treat chorea, reduce violent outbursts and agitation, and enhance strength, flexibility, balance, and coordination, which, in turn, improves the quality of life and enhances the patient's ability to carry out daily routine tasks, such as eating, communications, and walking. Furthermore, the increasing demand for advanced drugs to control the motor, cognitive, and psychiatric symptoms associated with Huntington's disease is providing an impetus to the market growth. In line with this, the rapid development of new disease-modifying drugs owing to the improved understanding of the disease, and its underlying causes are acting as another growth-inducing factor. Additionally, the recent development of the innovative therapeutic approach that deters the growth of Huntington's disease by reducing mutant huntingtin (mTT) production levels is positively influencing the market. Apart from this, the introduction of antisense technology that uses antisense oligonucleotides (ASOs) to target huntingtin (HTT) messenger ribonucleic acid (mRNA) and its protein throughout the central nervous system (CNS) is propelling the market growth. Moreover, increasing initiatives by several governments to promote the development of novel drugs are favoring the market growth. Other factors, including rising awareness among the masses regarding Huntington's disease, significant growth in the healthcare industry, increasing investment in research and development (R&D) activities, rising geriatric population, and escalating demand for off-label medications, are anticipated to drive the market growth.

Key Market Segmentation:

Type Insights:

  • Symptomatic Treatment
  • Disease-modifying Therapies
  • The report has also provided a detailed breakup and analysis of the Huntington's disease treatment market based on the type. This includes symptomatic treatment and disease-modifying therapies. According to the report, symptomatic treatment represented the largest segment.

Drug Type Insights:

  • Approved Drugs
  • Tetrabenazine
  • Deutetrabenazine
  • Off-label Drugs

Age Insights:

  • Below 50 Years
  • Above 50 Years

Distribution Channel Insights:

  • Drug Stores and Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

End User Insights:

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for Huntington's disease treatment. Some of the factors driving the North America Huntington's disease treatment market includes significant technological advancements, the rapid development of healthcare infrastructure, and the rising number of individuals suffering from Huntington's disease.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global Huntington's disease treatment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AOP Health, Apotex Inc., Dr. Reddy's Laboratories Ltd., H. Lundbeck A/S, Hikma Pharmaceuticals PLC, Lupin Limited, Prilenia Therapeutics, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Vaccinex Inc. etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What was the size of the global Huntington's disease treatment market in 2024?
  • 2. What is the expected growth rate of the global Huntington's disease treatment market during 2025-2033?
  • 3. What are the key factors driving the global Huntington's disease treatment market?
  • 4. What has been the impact of COVID-19 on the global Huntington's disease treatment market?
  • 5. What is the breakup of the global Huntington's disease treatment market based on the type?
  • 6. What is the breakup of the global Huntington's disease treatment market based on the drug type?
  • 7. What is the breakup of the global Huntington's disease treatment market based on the age?
  • 8. What is the breakup of the global Huntington's disease treatment market based on the distribution channel?
  • 9. What are the key regions in the global Huntington's disease treatment market?
  • 10. Who are the key players/companies in the global Huntington's disease treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Huntington's Disease Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Symptomatic Treatment
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Disease-modifying Therapies
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Approved Drugs
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Tetrabenazine
      • 7.1.2.2 Deutetrabenazine
    • 7.1.3 Market Forecast
  • 7.2 Off-label Drugs
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Age

  • 8.1 Below 50 Years
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Above 50 Years
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Drug Store and Retail Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospital Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Homecare
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Specialty Clinics
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 Drivers, Restraints, and Opportunities

  • 12.1 Overview
  • 12.2 Drivers
  • 12.3 Restraints
  • 12.4 Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 AOP Health
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Apotex Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 SWOT Analysis
    • 16.3.3 Dr. Reddy's Laboratories Ltd.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 H. Lundbeck A/S
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 Hikma Pharmaceuticals PLC
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Lupin Limited
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Prilenia Therapeutics
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Sun Pharmaceutical Industries Limited
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Teva Pharmaceutical Industries Ltd.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Vaccinex Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.